
An Update from MI Health—July 2024

FasterCures Quarterly Update—July 2024

Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials

Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561

Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health

Investing in Inclusion: How Blockchain Can Reshape Financial Futures

Is the Algorithm the New Political Agenda?

The Surprising Truth of Brand Marketers

Journey toward Collective Impact

We Aren’t Talking Enough About One Aspect of the Great Wealth Transfer
